What Does an Obesity Medicine Doctor Actually Do?

A plain look at the specialty, the standard of care, and what good obesity treatment should feel like from the inside.

An obesity medicine doctor treats excess weight as the chronic medical condition it is, not a character flaw or a cosmetic issue. What the doctor does is take a full history, order labs, find the specific biological and behavioral drivers of a person's weight, then build an individualized plan that combines medication, nutrition, activity, and behavior support, monitored and adjusted over time.

Is obesity medicine a real medical specialty?

Yes. Obesity is recognized as a chronic, relapsing medical condition by major medical organizations, and there is a defined body of knowledge for treating it. Physicians can pursue focused training and board certification in obesity medicine on top of their primary training. That matters because the field has moved a long way in a short time. We now understand a good deal about how the brain regulates appetite, how the body defends a higher weight after weight loss, and why willpower alone so often fails people who are trying hard.

I mention this early because many patients arrive apologizing. They have been told, directly or by implication, that their weight is a discipline problem. Part of my job is to correct that framing with the evidence, and then to get to work.

What happens in a first obesity medicine visit?

The first visit is an assessment, not a sales pitch. A careful history comes first: how a person's weight has changed over their life, what they have tried, what worked and for how long, family history, sleep, stress, mood, medications that can affect weight, and any conditions that travel with obesity such as type 2 diabetes, high blood pressure, fatty liver, or sleep apnea.

Labs fill in the picture the conversation cannot. Depending on the person, that can include blood sugar and A1c, a lipid panel, thyroid function, liver enzymes, and kidney markers. The point is to understand contributors. Two people at the same weight can have very different biology, different risks, and different right answers. A plan built without that information is a guess.

How does an obesity medicine doctor build a treatment plan?

There is no single protocol that fits everyone, and any clinic that hands you the same plan they hand the next person is skipping the part that makes this medicine. A real plan is assembled from several tools, weighted to the individual.

• Medication, when appropriate. GLP-1 based therapies have changed what is achievable. In the STEP-1 trial, semaglutide produced an average of about 14.9% of body weight lost, and in SURMOUNT-1, tirzepatide averaged about 20.9%. Those are averages from studies of the FDA-approved brand products. Compounded semaglutide and tirzepatide are not FDA-approved and are not identical to the brand versions, and results vary by individual.
• Nutrition that a person can actually keep, built around adequate protein and real food rather than a rigid diet with an expiration date.
• Behavior and habits, including sleep, stress, and the eating patterns that a medication can quiet but not erase.
• Activity, with particular attention to strength. This is not vanity. When weight comes off, lean tissue can account for roughly a quarter to 40% of the total lost. Pairing treatment with resistance training and enough protein, often cited around 1.2 to 2 grams per kilogram of body weight per day, helps protect muscle.

Why do obesity doctors keep monitoring and adjusting?

Because the body pushes back. Weight regulation is defended by biology, and a plan that fit at the start will need tuning as the body adapts, as side effects appear or fade, and as life changes. Good care means regular check-ins, honest tracking, and a willingness to change course. If a medication is not tolerated well, we adjust. If progress stalls, we look for why rather than simply telling someone to try harder.

This is also why obesity is managed as a long-term condition rather than a quick course of treatment. When medication is stopped, weight tends to return. In the SURMOUNT-4 study for tirzepatide and the STEP-1 extension for semaglutide, stopping the medication led to substantial regain over about a year. In the STEP-1 extension, roughly two-thirds of the lost weight came back within a year. That is not a failure of the person. It is the biology of the condition, and it is exactly why the plan has to be built to last.

Does an obesity doctor only care about the number on the scale?

No, and the newer evidence makes that clearer than ever. Weight is one marker among several, and often not the most important one. The same class of medicines now shows benefit well beyond the scale.

In the SELECT trial, semaglutide, sold as Wegovy (Novo Nordisk, a trademark of its owner; not affiliated), reduced major cardiovascular events by about 20% in adults with established cardiovascular disease and overweight or obesity who did not have diabetes. In the FLOW trial, in people with type 2 diabetes and chronic kidney disease, semaglutide reduced major kidney events by about 24% and death from any cause by about 20%. Tirzepatide, sold as Zepbound (Eli Lilly, a trademark of its owner; not affiliated), was approved for moderate-to-severe obstructive sleep apnea in December 2024 after the SURMOUNT-OSA study. And in the ESSENCE trial, semaglutide improved fatty liver disease and fibrosis, leading to an FDA approval in that setting in August 2025.

I share these not to promise any one person a specific outcome, but to make a point about the work. Treating obesity well often means improving blood pressure, blood sugar, sleep, energy, and mood. The person in front of me is not a number. They are someone who wants to feel better and live longer, and the number is only useful insofar as it serves that.

How does obesity medicine coordinate with the rest of your care?

Weight rarely travels alone. It intersects with cardiology, endocrinology, sleep medicine, mental health, and primary care. A responsible obesity physician communicates with the other clinicians involved, reviews the full medication list for interactions and for drugs that quietly drive weight up, and knows when a symptom belongs to someone else's expertise. Coordinated care is not a luxury. It is how you avoid treating one organ system while ignoring another.

What should you expect from good obesity care?

You should expect to be listened to before anyone reaches for a prescription pad. You should expect labs and a real assessment, a plan explained in plain language, honest talk about what a medication can and cannot do, and a clear picture of what long-term care looks like and what it costs. You should expect follow-up, and a clinician who adjusts rather than shrugs when something is not working.

At New Hope Weight Loss and Wellness, care is led by Dr. Anjmun Sharma, MD. The physician visit is $119, and programs are priced up front, with compounded semaglutide from $166 a month and compounded tirzepatide from $233 a month. We are cash-pay and telehealth, so no insurance is needed, and the conversation is private. The goal is simple to say and harder to do well: treat the whole person, over time, with evidence and with respect.

Frequently asked questions

This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.